跳至主要内容
临床试验/CTRI/2023/09/057467
CTRI/2023/09/057467招募中3 期

A pilot randomized controlled clinical trial to evaluate thehepatoprotective effect of ZingiVir-H in patients with elevatedliver enzyme panel - nil

Pankajakasthuri Herbals India Pvt lTD0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subjects of either gender with an age group between 18 - 70 years
  • Subjects having elevated liver enzymes panel due to multiple causes like obesity, hyper
  • triglyceridemia, drug induced liver disease etc.
  • Subjects with fluctuating liver enzyme panel due to unknown reasons.
  • Subjects who are willing to sign the informed consent form

排除标准

  • Patients with chronic liver diseases
  • Pregnant and lactating women
  • Suspected malignant conditions

研究者

发起方
Pankajakasthuri Herbals India Pvt lTD

相似试验

Clinical trial to evaluate thehepatoprotective... | 临床试验